Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02912390 · ClinicalTrials.gov registry record · NA
Cerclage for Short Cervix in Twins
A NA study, sponsored by St. Louis University.
- Terminated
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT02912390: Clinical Trial NA study, sponsored by St. Louis University.
NCT02912390 is a NA study that was terminated before completion, run by St. Louis University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02912390, a NA study, was terminated before completion, sponsored by St. Louis University.
- TERMINATED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
Through cervical length measurement in uncomplicated twin gestations, women with cervical length ≤ 25 mm will be approached for randomization to cerclage placement or expectant management with activity restriction and treatment of preterm labor
Primary Outcome
To determine whether cerclage placement in women with twin gestation and cervical length ≤ 25 mm results in pregnancy prolongation.
Interventions
- PROCEDURE Cerclage
- OTHER Expectant management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2017-01-12 |
| Est. Completion | 2018-04-11 |
| Phase | NA |
Why NCT02912390 stopped before completion
NCT02912390 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Cerclage is the first listed.
NCT02912390 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02912390 about?
NCT02912390 is a clinical study titled "Cerclage for Short Cervix in Twins". Through cervical length measurement in uncomplicated twin gestations, women with cervical length ≤ 25 mm will be approached for randomization to cerclage placement or expectant management with activity restriction and treatment of preterm labor
What is the current status of trial NCT02912390?
This trial is currently terminated. It is a NA study. The enrollment target is 9 participants. The study started on 2017-01-12. Estimated completion is 2018-04-11.
What interventions are being tested in trial NCT02912390?
The interventions under investigation include: Cerclage (PROCEDURE), Expectant management (OTHER).
Who is sponsoring clinical trial NCT02912390?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02912390's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI